A year in review: General Report of Activities 2023 published today

Today, the EMCDDA launches its General Report of Activities 2023, which provides an overview of key achievements and governance in a year steeped in significance. 'No previous year has bridged the future and the past more significantly than 2023 has done', states the report. In February, the EMCDDA commemorated 30 years since its creation, an event which had symbolised a major political decision to build drug policies on scientific evidence rather than ideology. In July, new legislation entered into force, setting the agency on a one-year transition course to becoming the new European…